Risk factor
Good trading liquidity
Profitability factor
Very favourable analyst view
About
Amoy Diagnostics Co., Ltd. is a diagnostics company focused on molecular diagnostic solutions for precision oncology. Operating both within China and across international markets, the firm provides a range of sophisticated assays, including Next-Generation Sequencing (NGS), real-time PCR, Fluorescence In Situ Hybridization (FISH), and various extraction methods. Established in 2008, Amoy Diagnostics has its base in Xiamen, China.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of 300685.SZ is 28.7 and suggests 64.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to